New Clinical Trial Proves Erchonia Medical’s Verjú Laser Safely and Effectively Improves the Appearance of Cellulite
6/25/2013 11:09:37 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MCKINNEY, Texas--(BUSINESS WIRE)--Erchonia today announces its new Verjú low level laser has been proven to safely and effectively treat cellulite in a double blind, randomized, multi-site and placebo-controlled clinical trial. In just two weeks with six treatments of Erchonia’s Verjú laser, patients experienced a significant improvement in the appearance of cellulite in their thighs, buttocks and lower abdomen when compared with those treated with the placebo laser.
Help employers find you! Check out all the jobs and post your resume.
comments powered by